Prevention of Post-sphincterotomy Bleeding by Tranexamic Acid and Sucralfate
Post-ERCP Bleeding
Enrolment: 120 · Results not recorded
Loading the evidence…
Drug · Forms a cytoprotective barrier by cross-linking mucosal glycoproteins and inhibits pepsin A; ATC A02BX02.
1 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Post-ERCP Bleeding
Enrolment: 120 · Results not recorded
Chronic Radiation Proctitis
Enrolment: 122 · Results not recorded
Laryngopharyngeal Reflux Disease
Enrolment: 800 · Results not recorded
Radiation Mucositis · Head and Neck Cancers
Enrolment: 100 · Results not recorded
Radiation Esophagitis
Enrolment: 142 · Results not recorded
Oral Mucositis · Nausea · Vomiting · Diarrhea
Enrolment: 180 · Results not recorded
1 studies reported at therapy level; 2 evidence entries itemised.
Model: Ethanol-induced gastric mucosal damage and chronic gastric and duodenal ulceration induced by serosal acetic acid
Sucralfate protected the gastric mucosa against ethanol damage and increased mucosal prostaglandin generation independently of endogenous epidermal growth factor, and enhanced healing of acetic acid ulcers. Ulcer healing was reduced by sialoadenectomy and partially restored by oral epidermal growth…
Extraction: extract · Supplied extraction confidence: 0.72. Machine-extracted fields require source verification.
Extraction: mesh. Machine-extracted fields require source verification.